Status:
COMPLETED
Coping Peer Intervention for Adherence
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
GlaxoSmithKline
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Eligibility:
All Genders
11-16 years
Phase:
NA
Brief Summary
Inner-city African American and Hispanic adolescents suffer from disproportionately high rates of emergency room visits and hospitalizations for acute exacerbations of asthma. This study proposes the ...
Detailed Description
High rates of asthma morbidity and mortality among inner-city African American and Hispanic adolescents demand urgent intervention. To address this disparity, the investigators have designed a cultura...
Eligibility Criteria
Inclusion
- Self-identify as African American or Hispanic
- 11-16 years of age
- Have persistent asthma
- Be on a prescription daily inhaled steroid medication for asthma
Exclusion
- Candidate refusal
- Presence of other co-morbidities that could interfere with study participation
- greater than 47% adherence to daily inhaled steroid medication as measured at baseline using the Doser CT
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT01169883
Start Date
July 1 2010
End Date
June 1 2012
Last Update
October 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612